NASDAQ · Price History

Metagenomi Therapeutics, Inc. (MGX) Stock Price History & Returns

$0.63 NASDAQ: MGX Market Cap $23.86M

Price history through Nov 17, 2026 · Source: Yahoo Finance (adjusted closes) (methodology)

How Metagenomi Therapeutics, Inc. (MGX) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.

The share price of $0.63 sits 2% of the way up a 52-week range of $0.60 to $1.87; 66.3% below the 52-week high; below its 50-day moving average of $0.95; below its 200-day average of $1.25; a beta of 0.67 means it has historically moved less than the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months-43.7%
6 months-47.2%
1 year-59.3%

Year by year

0 of 2 years closed higher than the year before. Closes are the last observation in each calendar year.

YearCloseChange
2026$0.63-62.3%
2025$1.67-53.9%

Monthly closing prices

The last 34 months, newest first. 8 of 33 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
November 2026$0.63-19.2%
October 2026$0.78-23.5%
September 2026$1.02-12.8%
August 2026$1.17-1.7%
July 2026$1.19-5.6%
June 2026$1.26-7.4%
May 2026$1.36-2.2%
April 2026$1.39+3.0%
March 2026$1.35-11.2%
February 2026$1.52-1.3%
January 2026$1.54-7.8%
December 2025$1.67-4.6%
November 2025$1.75-31.1%
October 2025$2.54-4.2%
September 2025$2.65+52.3%
August 2025$1.74-22.7%
July 2025$2.25+34.7%
June 2025$1.67-1.8%
May 2025$1.70+5.6%
April 2025$1.61+14.2%
March 2025$1.41-31.2%
February 2025$2.05-23.8%
January 2025$2.69-25.7%
December 2024$3.62+74.9%
November 2024$2.07-1.9%
October 2024$2.11+4.5%
September 2024$2.02-32.0%
August 2024$2.97-18.2%
July 2024$3.63-11.0%
June 2024$4.08-36.1%
May 2024$6.38+0.9%
April 2024$6.32-40.1%
March 2024$10.55-12.1%
February 2024$12.00—

Metagenomi Therapeutics, Inc. (MGX) price history — frequently asked questions

How has Metagenomi Therapeutics, Inc. performed over the last year?

Metagenomi Therapeutics, Inc. (MGX) has fallen 59.3% over the last twelve months, measured on price alone.

What is Metagenomi Therapeutics, Inc.'s five-year return?

Over five years the MGX share price has gained 0.0%, excluding dividends.

What is Metagenomi Therapeutics, Inc.'s 52-week range?

Over the last year Metagenomi Therapeutics, Inc. (MGX) has traded between $0.60 and $1.87.

Price returns of other Biotechnology stocks

VRTX 1-year +22.4%REGN 1-year +38.2%MRNA 1-year +740.3%RVMD 1-year +137.0%ROIV 1-year +92.3%INSM 1-year -36.3%UTHR 1-year +27.9%INCY 1-year +14.8%ALNY 1-year -63.6%ASND 1-year +33.4%All Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.